Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aohong Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of biochemical and chemical drugs. Based in Shenyang, the company is a core subsidiary of Fosun Pharma and is well-known for its flagship products in the cardiovascular and cerebrovascular therapeutic areas. Its key offerings include Aodejin, a deproteinized calf blood extract used for neurological recovery, and Bangting, a widely used hemostatic agent. Aohong maintains high-standard GMP manufacturing facilities and focuses on expanding its portfolio through both generic and innovative drug development. The company plays a vital role in the domestic Chinese market for injectable medicines and surgical support treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aohong Pharmaceutical.